T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study by Angyal, A, Longet, S, Moore, SC, Payne, RP, Harding, A, Tipton, T, Rongkard, P, Ali, M, Hering, LM, Meardon, N, Austin, J, Brown, R, Skelly, D, Gillson, N, Dobson, SL, Cross, A, Sandhar, G, Kilby, JA, Tyerman, JK, Nicols, AR, Spegarova, JS, Mehta, H, Hornsby, H, Whitham, R, Conlon, CP, Jeffery, K, Goulder, P, Frater, J, Dold, C, Pace, M, Ogbe, A, Brown, H, Ansari, MA, Adland, E, Brown, A, Chand, M, Shields, A, Matthews, PC, Hopkins, S, Hall, V, James, W, Rowland-Jones, SL, Klenerman, P, Dunachie, S, Richter, A, Duncan, CJA, Barnes, E, Carroll, M, Turtle, L, de Silva, TI

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine by Payne, RP, Longet, S, Austin, JA, Skelly, DT, Dejnirattisai, W, Adele, S, Meardon, N, Faustini, S, Al-Taei, S, Moore, SC, Tipton, T, Hering, LM, Angyal, A, Brown, R, Nicols, AR, Gillson, N, Dobson, SL, Amini, A, Supasa, P, Cross, A, Bridges-Webb, A, Reyes, LS, Linder, A, Sandhar, G, Kilby, JA, Tyerman, JK, Altmann, T, Hornsby, H, Whitham, R, Phillips, E, Malone, T, Hargreaves, A, Shields, A, Saei, A, Foulkes, S, Stafford, L, Johnson, S, Wootton, DG, Conlon, CP, Jeffery, K, Matthews, PC, Frater, J, Deeks, AS, Pollard, AJ, Brown, A, Rowland-Jones, SL, Mongkolsapaya, J, Barnes, E, Hopkins, S, Hall, V, Dold, C, Duncan, CJA, Richter, A, Carroll, M, Screaton, G, de Silva, TI, Turtle, L, Klenerman, P, Dunachie, S